Clinical epidemiology for childhood primary central nervous system tumors

Luc Bauchet1, Valérie Rigau, Hélène Mathieu-Daudé

  • 1Department of Neurosurgery, Centre Hospitalo-Universitaire, Hôpital Gui de Chauliac, 80 Avenue Augustin Fliche, 34-295, Montpellier cedex 5, France. l-bauchet@chu-montpellier.fr

Journal of Neuro-Oncology
|November 21, 2008
PubMed

Insights

The French Brain Tumor Data Bank (FBTDB) established a comprehensive registry of childhood primary central nervous system tumors (PCNST), collecting crucial clinical and histological data. This initiative aims to advance research and improve patient care for pediatric brain tumors.

Area of Science:

  • Neuro-oncology
  • Pediatric Oncology
  • Epidemiology

Background:

  • Primary central nervous system tumors (PCNST) are a significant health concern in children.
  • Accurate epidemiological data and comprehensive tumor registries are essential for advancing research and treatment.
  • The French Brain Tumor Data Bank (FBTDB) was established to address these needs.

Purpose of the Study:

  • To prospectively record all histologically confirmed primary central nervous system tumors (PCNST) in children in France.
  • To analyze socio-demographic, clinical, radiological, and anatomopathological data of childhood PCNST.
  • To establish a foundation for future epidemiological studies and research protocols.

Main Methods:

  • Prospective data collection by French neuropathology and neurosurgery departments.
  • Utilized a standardized data file for recording patient and tumor information.
  • Inclusion of histological diagnosis and cryopreservation of specimens.

Main Results:

  • Recorded 1,017 newly diagnosed childhood PCNST cases (2004-2006).
  • Gliomas constituted 52% of tumors, followed by other neuroepithelial tumors (31%).
  • Detailed distributions by histology, age, sex, tumor site, and surgical intervention were analyzed.

Conclusions:

  • This study represents the first European databank for PCNST with integrated clinical, radiological, and histological data.
  • The FBTDB provides a valuable resource for epidemiological studies and research in pediatric neuro-oncology.
  • Long-term goals include creating a national registry to harmonize healthcare and advance research for PCNST patients.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...